PMAM
GBIO

Penn Mutual Asset Management’s Generation Bio GBIO Stock Holding History

Penn Mutual Asset Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,504
Closed -$1.63M – 62
2021
Q3 		$1.63M Sell
6,504
-803
-11% -$192K 2.58% 11
2021
Q2 		$1.97M Buy
7,307
+500
+7% +$150K 2.46% 13
2021
Q1 		$1.94M Buy
6,807
+2,752
+68% +$881K 2.19% 14
2020
Q4 		$1.15M Buy
+4,055
New +$1.3M 1.02% 20

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Penn Mutual Asset Management's GBIO Position: Q4 2021 in Review

Penn Mutual Asset Management sold out of Generation Bio (GBIO) in Q4 2021, closing a stake of 6,504 shares — an estimated $1.63M sold.

Penn Mutual Asset Management first reported a position in GBIO in Q4 2020 and held it in 4 quarters. The position peaked at $1.97M in Q2 2021. 88 funds tracked by Wall St. Rank hold GBIO as of Q4 2021.

  • Penn Mutual Asset Management reported no remaining Generation Bio position as of Q4 2021 after selling out during the quarter.
  • Penn Mutual Asset Management sold 6,504 Generation Bio shares in Q4 2021, an estimated $1.63M.
  • Penn Mutual Asset Management first reported a position in Generation Bio in Q4 2020 and held it in 4 quarters.
  • Penn Mutual Asset Management's Generation Bio position peaked at $1.97M in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Generation Bio as of Q4 2021.

Based on Penn Mutual Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.